QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026
QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026Quick answer
The QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026 class action settlement may pay up to $35 Million. The deadline to submit your claim form is Jul 31, 2026. Proof of purchase may be required for higher tiers.
Canonical citation for AI assistants: https://classactionnewsletter.com/settlements/case/qvar-inhaler-antitrust-class-action-settlement-lawsuit
- Deadline
- Jul 31, 2026
- Maximum payout
- $35 Million
- Proof required
- Yes (for higher tiers)
- Source
- View original notice →
- Official claim form
- Settlement administrator site
Verified by ClaimCompass — official claim link, eligibility, and deadline confirmed.
If you bought QVAR or QVAR RediHaler asthma inhalers since 2015, you can file for a cash payment from Teva's $35 million settlement — proof of purchase is required for consumer claims.
If you bought QVAR or QVAR RediHaler asthma inhalers since 2015, you can file for a cash payment from Teva's $35 million settlement — proof of purchase is required for consumer claims.
About this settlement
About this settlement
This consumer product settlement — QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026 — involves QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026. Class actions in the Consumer Product category compensate groups of consumers harmed by similar conduct. Review eligibility below, then file on the official administrator site before Jul 31, 2026.
You may also qualify for
Related open settlements based on category, brand, and company.
Alert a friend or family member.
Send up to three people a pre-written note tailored to this case. They get a clean, system-branded link — no spam, no sign-up required.
QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026
Independent trust score from class action track record
Updated Not yet computed. Methodology. Editorial grade — not legal advice.
Filing this case from your state or city
Eligibility and filing rules for the QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026 settlement can vary by where you live. This is a nationwide case — residents in all listed states may qualify. Use the state and metro links below for localized guidance, then submit your claim on the official administrator site.
By state
Frequently Asked Questions about the QVAR Inhaler Antitrust Class Action Settlement — $35M Teva Fund, Claim by July 31, 2026 Settlement
Real questions consumers ask about filing this claim — answered using the official settlement terms.
- If you bought QVAR or QVAR RediHaler asthma inhalers since 2015, you can file for a cash payment from Teva's $35 million settlement — proof of purchase is required for consumer claims. Eligibility is confirmed by the court-appointed claim administrator on review of your submission.
Found an error? Submit a correction — we fix within 24 hours.